On August 18th, the National Health Commission held a press conference in Beijing to introduce the relevant information of the 4th China (Gansu) Traditional Chinese Medicine Industry Expo. It is reported that this year's Drug Expo is scheduled to be held from August 23rd to 26th in Dingxi City, Gansu Province. Qi Guixin, a first level inspector from the Planning Department of the National Health Commission, stated that the National Health Commission, the National Administration of Traditional Chinese Medicine, and the People's Government of Gansu Province have jointly held three sessions of the Drug Expo. The first three sessions have achieved fruitful results and significant results. With the joint efforts of all parties, the Pharmaceutical Expo has become a platform for policy interpretation, exchange and cooperation, achievement display, and cultural inheritance and innovation in the field of traditional Chinese medicine. It has gradually become a brand, playing an important role in accelerating the construction of a comprehensive experimental zone for the development of the national traditional Chinese medicine industry and promoting the development of the national traditional Chinese medicine industry. Ouyang Bo, Deputy Director of the Comprehensive Department of the National Administration of Traditional Chinese Medicine, stated that in order to better meet the expectations of the people for traditional Chinese medicine, the National Administration of Traditional Chinese Medicine is accelerating the establishment of a TCM service system covering the entire lifecycle, further optimizing the allocation of TCM resources in the high-quality and efficient medical service system, promoting the expansion, improvement, sinking, and balanced layout of high-quality TCM medical resources, and implementing the project to enhance grassroots TCM service capabilities, The accessibility of traditional Chinese medicine has greatly improved. In recent years, the Central Committee of the Communist Party of China and the State Council have issued a series of policies to promote the inheritance, innovation, and development of traditional Chinese medicine, leading to historic achievements and global changes in the field of traditional Chinese medicine. As a major province of traditional Chinese medicine in the western region, Gansu has seized opportunities for the development of traditional Chinese medicine, accelerated the development of its traditional Chinese medicine industry cluster, established an industrial chain development system covering the entire process of planting, warehousing, circulation, processing, scientific innovation, and use of traditional Chinese medicine, and promoted the high-quality development of the traditional Chinese medicine industry and services in Gansu Province. It is understood that Gansu is an important drug source base and a guarantee base for the production and supply of traditional Chinese medicine raw materials in China. According to Liu Borong, there are 3626 types of traditional Chinese medicine resources in the province, including over 220 artificially planted varieties, over 110 large-scale cultivation (aquaculture), and over 30 authentic medicinal herbs; Among the 363 key varieties in China, Gansu has 276. In 2022, the planting area of traditional Chinese medicine in Gansu Province was 4.91 million acres, with a standardized planting rate of 55% and a production capacity of 1.47 million tons. The static storage capacity of traditional Chinese medicine reached 1.3 million tons, and the annual trading volume of traditional Chinese medicine materials exceeded 1.5 million tons, both ranking among the top in the country. In 2023, the planting area will be around 5 million acres, and the yield is expected to reach 1.55 million tons. According to Wen Weidong, Deputy Secretary of the Municipal Party Committee of Dingxi City, Gansu Province, during the first three sessions of the Traditional Chinese Medicine Industry Expo, Dingxi City signed a total of 106 projects with a signed amount of 14.39 billion yuan, and introduced 11 leading pharmaceutical enterprises. The proportion of the added value of the traditional Chinese medicine industry in the regional GDP increased from 5.9% in 2018 to 8.1% in 2022, and the output value of traditional Chinese medicine processing enterprises increased from 3.5 billion yuan in 2018 to 7 billion yuan in 2022. In 2022, the output value of the entire traditional Chinese medicine industry chain in the city reached 42.5 billion yuan, achieving an added value of 4.624 billion yuan. Wen Weidong stated that out of more than 500000 households in Dingxi City, more than 330000 households are engaged in the cultivation of traditional Chinese medicine, with each household covering an area of